Can modulation of mammary gland development by dietary factors support breast cancer prevention?

Hormone Research

Volumn 68, Issue 5, 2007, Pages 248-260

  Wärri, Anni M ^a   Saarinen, Niina M ^a   Mäkelä, Sari I ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Breast cancer; Diet; Estrogen receptor; Isoflavone; Lignan; Mammary gland; Stem cell; Steroid action

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOID; GENISTEIN; ISOFLAVONE; LIGNAN; PHYTOESTROGEN; SECOISOLARICIRESINOL; STEROID HORMONE; TANNIN DERIVATIVE;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST DEVELOPMENT; CANCER PREVENTION; CANCER RISK; CANCER STEM CELL; DIET; GENE EXPRESSION; HUMAN; MAMMARY GLAND; MODULATION; MOLECULAR DYNAMICS; NONHUMAN; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUBERTY; REPRODUCTION; SHORT SURVEY; STEM CELL; TARGET CELL;

ANIMALS; BREAST NEOPLASMS; DIET; FEMALE; GONADAL STEROID HORMONES; HUMANS; ISOFLAVONES; LIGNANS; MAMMARY GLANDS, HUMAN; MODELS, BIOLOGICAL; PHYTOESTROGENS; POSTMENOPAUSE; PREGNANCY; PUBERTY; RISK FACTORS; STEM CELLS; TUMOR STEM CELLS;

EID: 34948904344     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102869     Document Type: Short Survey

References (100)

1. Cardiff RD: Are the TDLU of the human the same as the LA of mice? J Mammary Gland Biol Neoplasia 1998;3:3-5.
2. Cardiff RD, Wellings SR: The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 1999;4:105-122.
3. Russo J, Hu YF, Yang X, Russo IH: Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr 2000;27:17-37.
4. Nandi S, Guzman RC, Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995;92:3650-3657.
5. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible pre-cancerous lesions. J Natl Cancer Inst 1975;55:231-273.
6. Mikaelian I, Blades N, Churchill GA, Fancher K, Knowles BB, Eppig JT, Sundberg JP: Proteotypic classification of spontaneous and transgenic mammary neoplasms. Breast Cancer Res 2004;6:R668-R679.
7. Hovey RC, Trott JF, Vonderhaar BK: Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002;7:17-38.
8. Robinson GW, Karpf AB, Kratochwil K: Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999;4:9-19.
9. Wiesen JF, Young P, Werb Z, Cunha GR: Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 1999;126:335-344.
10. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS: Induction of mammary gland development in estrogen receptor-α knockout mice. Endocrinology 2000;141:2982-2994.
11. Master SR, Stoddard AJ, Bailey LC, Pan TC, Dugan KD, Chodosh LA: Genomic analysis of early murine mammary gland development using novel probe-level algorithms. Genome Biol 2005;6:R20.
12. Imagawa W, Pedchenko VK, Helber J, Zhang H: Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002;80:213-230.
13. Williams JM, Daniel CW: Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 1983;97:274-290.
14. Daniel CW, Silberstein GB, Strickland P: Direct action of 17β-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987;47:6052.
15. Mallepell S, Krust A, Chambon P, Brisken C: Paracrine signaling through the epithelial estrogen receptor-α is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 2006;103:2196-2201.
16. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA: Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 2002;99:15578-15583.
17. Lydon JP: A reappraisal of progesterone action in the mammary gland. J Mammary Gland Biol Neoplasia 2005;5:325.
18. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA: Essential function of wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000;14:650-654.
19. Mussi P, Liao L, Park SE, Ciana P, Maggi A, Katzenellenbogen BS, Xu J, O'Malley BW: Haploinsufficiency of the corepressor of estrogen receptor activity enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci USA 2006;103:16716-16721.
20. Mukherjee A, Soyal SM, Fernandez-Valdivia R, Gehin M, Chambon P, Demayo FJ, Lydon JP, O'Malley BW: Steroid receptor coactivator-2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol Cell Biol 2006;26:6571-6583.
21. O'Malley BW: Molecular biology. Little molecules with big goals. Science 2006;313:1749-1750.
22. Russo J, Ao X, Grill C, Russo IH: Pattern of distribution of cells positive for estrogen receptor-α and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 1999;53:217-227.
23. Kleinberg DL, Feldman M, Ruan W: IGF-I: An essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 2000;5:7-17.
24. Bonnette SG, Hadsell DL: Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 2001;142:4937-4945.
25. Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK, Lee AV: The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat 2006;98:315-327.
26. Anderson E, Clarke RB: Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia 2004;9:3-13.
27. Russo J, Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000;5:187-200.
28. Andres AC, Strange R: Apoptosis in the estrous and menstrual cycles. J Mammary Gland Biol Neoplasia 1999;4:221-228.
29. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM: An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000;5:227-241.
30. Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F: Refractoriness to mammary tumorigenesis in parous rats: Is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 1995;16:2847-2853.
31. Brisken C: Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 2002;7:39-48.
32. Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994;139:819-835.
33. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE: Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-228.
34. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME: Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558-1568.
35. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005;93:364-371.
36. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA: Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005;117:988-991.
37. Ma H, Bernstein L, Ross RK, Ursin G: Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res 2006;8:R39.
38. Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN: Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1509-1514.
39. Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S, Thor AD: Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 2003;63:2425-2433.
40. Medina D: Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 2005;12:483-495.
41. Sivaraman L, Medina D: Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 2002;7:77-92.
42. Murray AW, Edwards EM, Hii CS: Tumor promotion: biology and molecular mechanisms; in Cooper CS, Grove PL (eds): Chemical Carcinogenesis and Mutagenesis. Berlin, Springer, 1990, pp 135-149.
43. Smith GH, Boulanger CA: Mammary epithelial stem cells: transplantation and selfrenewal analysis. Cell Prolif 2003;36(suppl 1):3-15.
44. Kenney NJ, Smith GH, Lawrence E, Barrett JC, Salomon DS: Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J Biomed Biotechnol 2001;1:133-143.
45. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE: Generation of a functional mammary gland from a single stem cell. Nature 2006;439:84-88.
46. Smalley MJ, Clarke RB: The mammary gland 'side population': a putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia 2005;10:37-47.
47. Stingl J, Raouf A, Emerman JT, Eaves CJ: Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 2005;10:49-59.
48. Smalley M, Ashworth A: Stem cells and breast cancer: a field in transit. Nat Rev Cancer 2003;3:832-844.
49. Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas JE, Wang R, Russo IH: The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 2006;11:151-172.
50. Wagner KU, Smith GH: Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 2005;10:25.
51. Smith GH: Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005;132:681-687.
52. Booth BW, Smith GH: Estrogen receptor-α and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res 2006;8:R49.
53. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253-1270.
54. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004;101:4966-4971.
55. Wicha MS: Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis. Breast Cancer Res 2006;8:109.
56. Bissell MJ, Labarge MA: Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005;7:17-23.
57. 3 , and differentiation in the rodent mammary gland. Mol Endocrinol 2002;16:2034-2051.
58. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA: Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 2006;66:6421-6431.
59. Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, Moral R, Russo J: Genomic signature induced by pregnancy in the human breast. Int J Oncol 2006;28:399-410.
60. Verlinden I, Gungor N, Wouters K, Janssens J, Raus J, Michiels L: Parity-induced changes in global gene expression in the human mammary gland. Eur J Cancer Prev 2005;14:129-137.
61. WHO: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
62. Finnish Cancer Organisations: http://www.cancerregistry.fi/eng/
63. Lamartiniere CA, Zhang JX, Cotroneo MS: Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am J Clin Nutr 1998;68:1400S-1405S.
64. Hilakivi-Clarke L, Cho E, deAssis S, Olivo S, Ealley E, Bouker KB, Welch JN, Khan G, Clarke R, Cabanes A: Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr 2001;131:154S-157S.
65. Gikas PD, Mokbel K: Phytoestrogens and the risk of breast cancer: a review of the literature. Int J Fertil Womens Med 2005;50:250-258.
66. Smeds AI, Hakala K, Hurmerinta TT, Kortela L, Saarinen NM, Makela SI: Determination of plant and enterolignans in human serum by high-performance liquid chromatography with tandem mass spectrometric detection. J Pharm Biomed Anal 2006;41:898-905.
67. Cassidy A, Brown JE, Hawdon A, Faughnan MS, King LJ, Millward J, Zimmer-Nechemias L, Wolfe B, Setchell KD: Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 2006;136:45-51.
68. Saarinen NM, Smeds A, Makela SI, Ammala J, Hakala K, Pihlava JM, Ryhanen EL, Sjoholm R, Santti R: Structural determinants of plant lignans for the formation of enterolactone in vivo. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:311-319.
69. Axelson M, Setchell KD: The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 1981;123:337-342.
70. Heinonen SM, Hoikkala A, Wahala K, Adlercreutz H: Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 2003;87:285-299.
71. Penalvo JL, Heinonen SM, Aura AM, Adlercreutz H: Dietary sesamin is converted to enterolactone in humans. J Nutr 2005;135:1056-1062.
72. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930.
73. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor-β. Endocrinology 1998;139:4252-4263.
74. Miksicek RJ: Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Biol Med 1995;208:44-50.
75. Makela S, Davis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS: Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 1994;102:572-578.
76. Fritz WA, Coward L, Wang J, Lamartiniere CA: Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998;19:2151-2158.
77. Rowlands JC, Hakkak R, Ronis MJ, Badger TM: Altered mammary gland differentiation and progesterone receptor expression in rats fed soy and whey proteins. Toxicol Sci 2002;70:40-45.
78. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson JA, Khan G, Hilakivi-Clarke L: Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 2004;25:741-748.
79. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990;62:244-278.
80. Tan KP, Chen J, Ward WE, Thompson LU: Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood) 2004;229:147-157.
81. Tou JC, Thompson LU: Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 1999;20:1831-1835.
82. Ward WE, Jiang FO, Thompson LU: Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures. Nutr Cancer 2000;37:187-192.
83. Thomsen AR, Almstrup K, Nielsen JE, Sorensen IK, Petersen OW, Leffers H, Breinholt VM: Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile. Toxicol Sci 2006;93:357-368.
84. Padilla-Banks E, Jefferson WN, Newbold RR: Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor levels. Endocrinology 2006;147:4871-4882.
85. Nagasawa H, Yanai R, Shodono M, Nakamura T, Tanabe Y: Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17β level in rats. Cancer Res 1974;34:2643-2646.
86. Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman M: A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 1997;94:9372-9377.
87. Gallo D, Zannoni GF, Martinelli E, Ferlini C, Fabrizi M, Riva A, Morazzoni P, Bombardelli E, Scambia G: Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland. Menopause 2006;13:72-79.
88. Santell RC, Chang YC, Nair MG, Helferich WG: Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 1997;127:263-269.
89. Foth D, Cline JM, Romer T: Effect of isoflavones on mammary gland and endometrium of postmenopausal macaques (Macaca fascicularis). Zentralbl Gynäkol 2000;122:96-102.
90. Wood CE, Appt SE, Clarkson TB, Franke AA, Lees CJ, Doerge DR, Cline JM: Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol Reprod 2006;75:477-486.
91. Hilakivi-Clarke L, de Assis S: Fetal origins of breast cancer. Trends Endocrinol Metab 2006;17:340.
92. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Clin Cancer Res 2004;10:327S.
93. AICR: Diet and cancer: http://www.aicr.org/site/PageServer?pagename = dc_home
94. Delclos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton A, Weis CC, Newbold RR: Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol 2001;15:647-663.
95. You L, Sar M, Bartolucci EJ, McIntyre BS, Sriperumbudur R: Modulation of mammary gland development in prepubertal male rats exposed to genistein and methoxychlor. Toxicol Sci 2002;66:216-225.
96. Wuttke W, Rimoldi G, Christoffel J, Seidlova-Wuttke D: Plant extracts for the treatment of menopausal women: Safe? Maturitas 2006;55:S92-S100.
97. Fielden MR, Fong CJ, Haslam SZ, Zacharewski TR: Toxicol Lett 2002;133:181-191.
98. Nikaido Y, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A: Effects of prepubertal exposure to xenoestrogen on development of estrogen target organs in female CD-1 mice. In Vivo 2005;19:487-494.
99. Satoh K, Hovey RC, Malewski T, Warri A, Saito K, Goldhar A, Ginsburg E, Lydon JP, Vonderhaar BK: Progesterone enhances branching porphogenesis in the mouse mammary gland throuh regulation of expression of Msx-2. Oncogene 2007, in press.
100. Hilakivi-Clarke L, Cho E, Clarke R: Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol Rep 1998;5:609-616.